In a statement published by the government’s drug watchdog, the National Institute for Health and Clinical Excellence (NICE), this month it was confirmed that guidance first released in 2006 concerning the use of certain Alzheimer’s drugs will remain unchanged, despite massive objection from campaigners across the UK.Following an extended series of consultations with stakeholders which…